The TMX group is pleased with the recent decision by the U.S. Securities Exchange Commission to grant a national securities exchange license to the Boston Options Exchange (BOX).
Canadian exchanges, when compared with those in the U.S. and U.K., report and litigate the lowest percentage of financial fraud cases each year. Unfortunately, this doesn’t mean Canadian fraudsters aren’t out there—it means our regulators aren’t catching them.
The strength of Canada’s banks has become the stuff of international legend, having skated through the 2008 global financial crisis unscathed. The official story is that strong regulation saved the day. Unofficially, there’s a different story.
The Securities and Exchange Commission today charged a former executive at Morgan Stanley, Garth R. Peterson, for secretly acquiring millions of dollars in real estate investments for himself and a Chinese official who steered business to Morgan Stanley’s funds. Peterson violated the Foreign Corrupt Practices Act, as well as the securities laws for investment advisers. […]
A hearing panel of the Investment Industry Regulatory Organization of Canada (IIROC) accepted a settlement agreement between the IIROC staff, Trapeze Capital Corp., Herbert Abramson and Randall Abramson. Trapeze Capital Corp., Herbert Abramson and Randall Abramson admitted they inaccurately assessed the risk associated with many of the investments purchased on behalf of clients in managed […]
The federal government is working with the provinces in an attempt to finally create a common securities regulator within Canada. It will replace the patchwork of 13 regional regulators currently in existence.
A disciplinary hearing in the matter of Bill Hsueh was held Thursday in Toronto before a three-person hearing panel of the MFDA's Central Regional Council.
A disciplinary hearing in the matter of Bayant S. Dhindsa was held this week in Vancouver, British Columbia before a three-person hearing panel of the MFDA's Pacific Regional Council.
A Goldman Sachs investment banker, Matthew Korenberg, is currently the subject of a long-running probe by federal prosecutors in California— he allegedly shared information about pharmaceutical mergers with an employee of the Galleon Group.
On March 29, 2012 a hearing panel of the Investment Industry Regulatory Organization of Canada (IIROC) accepted a settlement agreement between IIROC staff and Alain Laroche.